Treatment of psoriasis with fumaric acid esters (Fumaderm®)
Authors:
- Ulrich MrowietzUlrich Mrowietz
- Peter AltmeyerPAPeter Altmeyer
- Thomas BieberTBThomas Bieber
- Martin RöckenMRMartin Röcken
- Rudolf E. SchopfRSRudolf E. Schopf
- Wolfram SterryWSWolfram Sterry
- 17 July 2007
- journal article
- practice guideline
- Published by Wiley in JDDG: Journal der Deutschen Dermatologischen Gesellschaft
- Vol. 5 (8) , 716-717
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- S3‐Leitlinie zur Therapie der Psoriasis vulgarisJDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2006
- Long-term safety aspects of systemic therapy with fumaric acid esters in severe psoriasisBritish Journal of Dermatology, 2003
- Topical Calcipotriol plus Oral Fumaric Acid Is More Effective and Faster Acting than Oral Fumaric Acid Monotherapy in the Treatment of Severe Chronic Plaque Psoriasis vulgarisDermatology, 2002
- Treatment of severe psoriasis with fumaric acid esters: scientific background and guidelines for therapeutic useBritish Journal of Dermatology, 1999
- Treatment of psoriasis with fumaric acid esters: results of a prospective multicentre studyBritish Journal of Dermatology, 1998
- Das Wirkungs- und Sicherheitsprofil von Fumarsäureestern in der oralen Langzeittherapie bei schwerer therapieresistenter Psoriasis vulgarisDie Dermatologie, 1996
- Antipsoriatic effect of fumaric acid derivativesJournal of the American Academy of Dermatology, 1994